CBP sees additions of national monthly statements and line-level liquidations among the top recommendations within the agency's simplified processes initiative, said Randy Mitchell, director of the Commercial Operations and Entry Division, during a March 24 webinar sponsored by the National Customs Brokers & Forwarders Association of America. National monthly statements, which would consolidate port-specific entry statements into a single statement, would likely be phased in, he said. Line-level liquidation would be a "longer-term" goal due to some "legal and regulatory factors" involved, Mitchell said. Other "top recommendations" include monthly entry summaries and the elimination of the separate 09 entry type for reconciliation by allowing for Post-Summary Corrections instead, he said.
CBP issued the following releases on commercial trade and related matters:
CBP issued the following release on commercial trade and related matters:
CBP forms 28 (Request for Information) and 29 (Notice of Action) are increasingly going straight to importers of record and no copy going to customs brokers, customs brokerage CPH Group said in an email (here). "With the CEEs coming into full force it has become more common that Customs Form (CF) 28 and CF 29 go directly to the importer of record, without the broker receiving a courtesy copy," it said. "If you receive either a CF 28 Customs Request for Information and/or CF 29 Notice of Action, it is vital to keep your customs broker in the loop! It's also important to note that the ACE Secure Data Portal allows authorized users to receive and respond to both of these notices." CBP didn't comment.
CBP issued the following releases on commercial trade and related matters:
The Food and Drug Administration recently deployed a web service that will allow importers and customs brokers to access FDA’s product code builder database through the ACE Automated Broker Interface (ABI), CBP said in a CSMS message (here). The product code builder application program interface released March 20 will allow software developers to build a user interface for the product code builder in ABI, FDA said (here). “This does not replace the current online Product Code Builder but compliments it by providing trade a method to program existing software to query and verify FDA Product Codes,” it said.
CBP issued the following releases on commercial trade and related matters:
CBP issued the following release on commercial trade and related matters:
CBP issued the following releases on commercial trade and related matters:
CBP issued the following releases on commercial trade and related matters: